Henry Meds HRT Alternatives: 10 Options Compared for Women

Disclosure: We may earn a commission from some links on this page. Sponsored links are labeled. Affiliate status does not determine which providers are included or what we conclude. Full disclosure

Henry Meds costs $149 a month for women ages 35 to 59, but the best answer among Henry Meds HRT alternatives depends on what Henry does not solve. Choose Midi Health for commercial PPO insurance, Elektra Health for eligible Medicare or Medicaid plans, Alloy for one FDA-approved medication, or Stella when Henry’s age gate excludes you.

That is the short answer. Here is the part almost nobody has written down.

We read Henry’s women’s HRT page, its published program schedule, its terms of service, and its refunds policy side by side. They do not all answer the same questions. The $149 package has dose ceilings that are missing from the product page. A $30 consultation component becomes nonrefundable when a prescription is issued. And the refund door described in the marketing FAQ is wider than the one in the policy that governs the refund.

None of that makes Henry a bad company. Some of it makes Henry look better than its competitors. But you should know all of it before your next billing date, and every material finding below links back to the page where it lives.

Best for / not for you if

Henry Meds may still be right for you if: you are 35 to 59, eligible in your state, paying cash, and want a predictable $149 payment that covers the clinical review, prescribed medication within the published program limits, supplies, and shipping. Henry also gives you a direct provider encounter and clearly labels its creams as compounded and its patch and tablets as FDA-approved products.

Henry Meds is not right for you if: you are outside its age range, need your insurance billed, want a provider that accepts your Medicare or Medicaid plan, only need one inexpensive prescription, need a route or dose Henry cannot confirm at the base price, or want to avoid compounded medication entirely.

One boundary before we compare anything: age 60 is Henry’s program cutoff, not a universal medical cutoff for hormone therapy. Decisions after 60 or 65 depend on symptoms, treatment goals, medical history, product, route, and dose—not a single birthday.

If this is your situation	Start with	Published cost structure	The catch
I want commercial insurance to pay for visits	Midi Health	Copay/coinsurance, or $250 first visit and $150 follow-ups self-pay	No Medicare coverage; Medicaid and Medi-Cal patients cannot be treated even as self-pay
I have Medicare or Medicaid	Elektra Health	Plan-specific; self-pay is available	Only selected plans and states are in-network—verify before booking
I only need one FDA-approved menopause medication	Alloy	$49 one-time consultation, then each product separately	Costs stack when the regimen needs more than one product
Henry’s age limit excludes me	Stella, Alloy, Elektra, or a local clinician	Stella: $200 initial and $90 follow-up self-pay; others vary	Clinical eligibility still depends on your history, not age alone
I want a bundled shipment like Henry	Winona or Inner Balance/Oestra	Product or subscription pricing	Winona has the same 35–59 HRT age range; Oestra is compounded
I want the recurring provider subscription to stop	Midi, Alloy, Gennev, MyMenopauseRx, Stella, Elektra, or a local clinician	Per visit or one-time consultation	Medication and lab costs may be separate

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

---

Why do so many Henry Meds alternatives pages talk about weight loss instead of women’s HRT?

Henry sells several telehealth programs, and most older coverage focused on its weight-management business. Its current program schedule places women’s HRT beside GLP-1 weight management, phentermine, men’s testosterone therapy, and erectile-dysfunction programs. That is why a search for Henry Meds alternatives can return prices and competitors that have nothing to do with menopause care.

That is not a criticism. It is the first distinction you need to make.

Henry’s women’s HRT program is currently $149 per month. A page quoting a higher Henry price may be describing a weight-management program, not women’s hormone therapy. And a page recommending weight-loss companies has not answered this query at all.

Henry is a general telehealth platform that offers menopause care. Midi, Elektra, Stella, Gennev, Alloy, and MyMenopauseRx position menopause or midlife women’s care much closer to the center of their clinical model. If you want a company whose public-facing practice is built around menopause, that is a real reason to look elsewhere—and a fair one.

Source: Henry Meds’ published program schedule, last updated December 3, 2025.

---

What does Henry Meds’ $149 a month actually include?

Henry Meds publishes a $149 monthly women’s HRT package covering estrogen and progesterone options within stated dose ceilings. Its product page says the subscription includes the treatment plan, medication and supplies, and shipping. Testosterone cream is a separate $100 monthly add-on if a licensed clinician prescribes it.

The phrase that matters is within stated dose ceilings.

Henry’s program schedule—not the main product page—lists:

• Up to 2 mg estradiol tablets
• Up to a 0.1 mg estradiol patch
• Up to 1 mg Bi-Est estradiol/estriol cream
• Up to 200 mg micronized progesterone tablets
• Up to 200 mg progesterone cream
• Up to 2 mg testosterone cream for an additional $100 per month, if prescribed

Those limits may cover many common regimens. They still exist, and Henry does not publish what happens to the price if a clinician recommends something outside them. Ask before the prescription is issued, not after.

Which Henry products are FDA-approved, and which are compounded?

Henry deserves credit here: it labels the regulatory status on the product cards instead of making you infer it from phrases such as “personalized” or “bioidentical.”

Product shown by Henry	Route	Henry’s label	Practical meaning
Body cream	Applied to skin	Compounded	The finished medication is not FDA-approved and is not reviewed by FDA before dispensing for safety, effectiveness, or quality
Vaginal cream	Applied locally	Compounded	Do not treat it as equivalent to an FDA-approved vaginal estrogen product
Estradiol patch	Transdermal	FDA-approved	Confirm the exact manufacturer, strength, and label on the dispensed product
Oral tablets	Oral	FDA-approved	Confirm the exact drug and strength prescribed
Testosterone cream	Topical	Compounded	Prescription-only; testosterone is a Schedule III controlled substance in the United States

Product labels verified on Henry’s women’s HRT page, August 17, 2026.

The Henry Meds Fine-Print Ledger

This is the part that did not exist in one place before this page. Each row compares a public-facing statement with the operative detail in another Henry-owned document.

What the public page leads with	What another Henry document adds	Why it matters
“$149/month” for women’s HRT	The program schedule lists dose ceilings for estradiol, Bi-Est, progesterone, and the $100 testosterone add-on	Ask what happens if your prescribed dose or route falls outside the schedule
One payment includes the provider visit, medication, supplies, and care	The terms and refund policy allocate $30 of a prescription-producing evaluation to a nonrefundable consultation fee	Once a prescription is issued, that $30 is deducted from any approved refund even if you do not continue
No processing fee is shown on the product page	The refund policy permits a “reasonable processing fee” in addition to the $30 consultation fee	The amount is not published—ask for it before relying on a refund estimate
The FAQ says a medical reason may release a multi-month balance	The refund policy requires outside MD/DO/NP/PA documentation that continued therapy is medically contraindicated, plus Henry clinical-team approval	“My clinician told me to stop” and “the policy approves a prorated refund” are not the same thing
Henry’s terms discuss Quest or Tasso laboratory workflows and say affiliated-lab costs are included when ordered through the platform	The women’s HRT line in the program schedule does not promise a standard panel or routine lab cadence	“Lab cost included if ordered through Henry” is not the same as “routine women’s HRT labs are included”
The product page shows a compounded vaginal cream	The women’s published price schedule does not list a vaginal cream	Confirm whether it is covered by the $149 package before the prescription is issued
The FAQ publishes shipment language for injectables and oral tablets	It does not publish a women’s cream or patch refill interval	Ask how many days of your exact product each shipment contains
“Cancel at any time”	The terms say to cancel at least 48 hours before the end of the current term to stop renewal	Use the 48-hour deadline, not the looser marketing phrase
Arbitration is not part of the product pitch	The terms require individual arbitration unless you opt out in writing within 30 days of first accepting them	The opt-out exists, but the clock is short

The fair explanation comes first: marketing pages summarize; legal policies govern edge cases. They do not have to use identical sentences. But when your money depends on the difference, you need the governing version.

Four questions before your next billing date:

1. Are labs clinically required for me, and are all ordered labs included through Henry’s network?
2. What is the refill interval for my exact patch, tablet, or cream?
3. Is the vaginal cream included at $149?
4. What processing fee would be deducted from an approved refund?

If Henry answers all four clearly, it may remain a perfectly good fit. If it cannot, you now know exactly which uncertainty another care model needs to remove.

Before you compare ten companies, eliminate the ones that cannot serve your age, state, coverage, or medication preference. Match your situation with Find My HRT Path.

Primary sources: Henry HRT page · Program schedule · Terms of service · Refunds, Returns & Replacements Policy

---

What are the best Henry Meds HRT alternatives?

Ten routes solve different parts of the Henry problem: insurance, age eligibility, one-product pricing, menopause-specialist care, FDA-approved-only prescribing, or freedom from a recurring provider subscription. No single option wins every column. The useful comparison is not “which homepage has the smallest number?” It is “which care model removes the reason I am leaving?”

Alternative	Public price and billing	Insurance	Medication status	Labs and visit model	Best fit / main blocker
1. Midi Health (sponsored link)	$250 initial and $150 follow-up self-pay; no membership fee	Most commercial PPO plans; no Medicare coverage; cannot treat Medicaid or Medi-Cal patients even as self-pay	Exact prescription varies; ordinary prescriptions go to your pharmacy. Women’s testosterone pathway is separately labeled compounded	Live video; labs ordered as clinically appropriate and billed separately	Best for commercial PPO coverage and no provider subscription / not for Medicaid or Medi-Cal
2. Alloy	$49 one-time consultation; estradiol pill from $39.99/mo, gel or Evamist $69.99/mo, patch $100/mo, progesterone from $23/mo	Cash-pay; HSA/FSA eligible	Published menopause hormone line uses FDA-approved products	Asynchronous intake and unlimited doctor messaging; no routine lab package published	Best for one medication and clear product pricing / costs stack with multi-product regimens
3. Elektra Health	Copay/coinsurance if in-network; self-pay available, amount confirmed at booking	Selected commercial, Medicare, and Medicaid plans in specified states	Company states it prescribes FDA-approved hormonal and nonhormonal medications, not compounded HRT	Live clinical visit; labs and prescriptions as needed; coaching support	Best documented virtual route for some Medicare/Medicaid patients / footprint is plan- and state-specific
4. Stella	$200 initial, $90 follow-up self-pay	Advertises in-network care; otherwise self-pay/superbill terms apply	Confirm exact prescribed product	Live virtual menopause clinic	Best when Henry’s 35–59 gate excludes you; Stella says it is designed for ages 35–70 / coverage varies
5. MyMenopauseRx	$150 per virtual visit self-pay	Major plans listed; plan and state eligibility vary	Company markets FDA-approved therapeutic options	Live visit; prescriptions to your pharmacy; discounted self-pay labs	Best for specialist-style care with insurance or a flat self-pay visit / not an all-in medication bundle
6. Gennev	$250 initial, $199 follow-up self-pay	Insurance accepted; specific plan/network rules vary	Verify the exact prescribed product at the pharmacy	30-minute video visits; prescriptions sent to pharmacy; nationwide video availability stated	Best for all-state menopause-focused video care / higher cash visit fees and medication separate
7. Sesame (sponsored link)	From $59/month for menopause care; medication not included	Does not bill insurance for the subscription	Publishes a formulary of FDA-approved brand and generic products	Video visits, messaging, and basic labs if clinically necessary	Best for a low care-subscription price with an included basic-lab promise / medication remains separate
8. Winona (sponsored link)	Product pricing: patch from $149/mo, progesterone capsules from $39/mo, estrogen tablets from $54/mo, creams from $89/mo	Cash-pay; HSA/FSA eligible	Patch, estrogen tablets, and progesterone capsules labeled FDA-approved; creams compounded	Primarily messaging-based, shipped medication	Best for a shipped bundle or product subscription / same 35–59 HRT age range as Henry
9. Inner Balance / Oestra	$199/mo for months 1–6, then $99.50/mo; ships 90 days at a time and bills monthly	Cash-pay; HSA/FSA eligible	Compounded; not FDA-approved	Async clinician review, messaging, no standard labs required to start; dose changes may cost extra	Best only when a clinician specifically chooses this combined compounded route / not cheaper than Henry in year one
10. Your own clinician + pharmacy	Visit cost plus the live price of the prescribed medication	Whatever your plan and pharmacy benefit cover	Whatever exact FDA-approved or compounded product is prescribed	In-person or established telehealth relationship; clinician orders labs	Often the cleanest route when you already have a clinician and pharmacy benefit / requires you to coordinate the pieces

Commercial facts verified August 17, 2026 on provider-owned pages. A listed public price is not a promise that you qualify for that medication or schedule. Prescribing remains a clinician’s decision.

---

Which Henry Meds alternative fits the reason you are leaving?

The constraint decides the answer. Leaving over insurance points somewhere different from leaving over age, one-product pricing, compounded medication, or automatic renewal. Find your actual reason below. The row that disqualifies a provider is more valuable than the row that makes it look attractive.

Your reason	The constraint that decides it	Best place to look
“I want insurance to pay.”	Henry is self-pay. Visit, lab, and prescription coverage are three separate benefits.	Midi for many commercial PPO plans; Elektra for specific Medicare/Medicaid and commercial plans; Stella, MyMenopauseRx, or Gennev depending your plan and state
“I am turning 60.”	Winona has the same HRT age range. Henry’s limit is a company eligibility rule, not a medical rule.	Stella (designed for 35–70), Alloy, Elektra, Midi if coverage fits, MyMenopauseRx, Gennev, or a local clinician
“I pay $149 for one prescription.”	Bundles price the program, not your exact regimen.	Alloy for transparent per-product cash pricing, or a clinician who sends a generic prescription to your pharmacy
“I want FDA-approved products only.”	Henry already offers an FDA-approved patch and tablets, but its creams are compounded.	Ask Henry for a labeled FDA-approved option, or compare Alloy, Elektra, and MyMenopauseRx; verify the exact product before payment
“I need vaginal estrogen.”	Henry shows a compounded vaginal cream but does not list it in the women’s price schedule.	Confirm Henry’s price first; then compare Alloy, Sesame, Midi, or your own clinician for an exact FDA-approved local product when appropriate
“I need testosterone evaluated.”	Testosterone is a Schedule III controlled substance. Availability depends on clinician judgment, state law, monitoring, and the provider’s controlled-substance pathway.	Henry publishes a compounded cream add-on. Midi and Elektra publish limited women’s testosterone pathways. Confirm your state and required labs before booking.
“I want the subscription to stop.”	A cheaper subscription is still a subscription.	Midi, Gennev, MyMenopauseRx, Stella, or Elektra for per-visit care; Alloy for a one-time consultation plus product billing; or a local clinician

There is no shame in choosing the boring route. If your own clinician will prescribe an appropriate product and your pharmacy benefit works, you do not need a telehealth subscription to prove you are taking menopause seriously.

---

What do Henry Meds alternatives really cost in the first year?

Henry’s reproducible base is $1,788 for twelve months. But the comparison changes once you separate care fees from medication, monthly billing from every-three-month billing, and a headline ongoing rate from an introductory period. The table below shows only arithmetic that can be rebuilt from a current public price; everything else stays “confirm at booking.”

Four different things get called a monthly HRT price:

1. All-in bundle: visit access, medication, supplies, and shipping in one recurring payment.
2. Care subscription plus separate pharmacy: the monthly fee buys clinical access; medication costs extra.
3. Per visit plus separate pharmacy: the provider bills each appointment and sends the prescription out.
4. One-time consultation plus product billing: the consultation does not recur, but medications do.

You cannot compare those models by reading one number in a hero banner.

Route	Reproducible arithmetic	What is and is not included
Henry Meds base	$149 × 12 = $1,788	Published bundle within program limits
Henry + testosterone cream	($149 + $100) × 12 = $2,988	Only if a clinician prescribes the compounded testosterone add-on
Alloy estradiol tablets	$49 + ($39.99 × 12) = $528.88	Consultation and advertised medication price; other products add cost
Alloy estradiol patch	$49 + ($100 × 12) = $1,249	Patch is shipped and billed in three-month supplies; progesterone not included
Alloy patch + progesterone illustration	$49 + (($100 + $23) × 12) = $1,525	Minimum based on advertised component prices, only if both are prescribed at those prices
Midi cash, two-visit illustration	$250 + $150 = $400 in care fees	Medication and labs separate; more visits increase cost
Stella cash, initial + one follow-up	$200 + $90 = $290 in care fees	Medication and labs separate
MyMenopauseRx, one self-pay visit	$150 in care fees	Medication and labs separate; additional visits add cost
Gennev cash, initial + one follow-up	$250 + $199 = $449 in care fees	Medication and labs separate
Sesame annual care fee	$59 × 12 = $708 plus medication	Basic labs are included if clinically necessary; medication is not
Winona patch + progesterone illustration	($149 + $39) × 12 = $2,256	Illustration from current advertised monthly components; confirm exact prescription and billing cadence at checkout
Inner Balance / Oestra	($199 × 6) + ($99.50 × 6) = $1,791	Compounded product, shipping, and clinical access; dose adjustments may cost extra
Local clinician + pharmacy	Get a live quote	Visit, lab, and medication costs depend on insurance, product, dose, pharmacy, and discount eligibility

Why the Oestra $99.50 headline is not the first-year price

Inner Balance advertises Oestra at $199 a month for the first six months, then $99.50 a month.

Run it out:

• Months 1–6: $199 × 6 = $1,194
• Months 7–12: $99.50 × 6 = $597
• First year: $1,791

Henry’s base year is $1,788.

The option with the lower ongoing headline is $3 more expensive in the first year. After month six, Oestra’s published ongoing rate is lower. But a woman switching during year one to save money has not saved money on the published base prices.

That is not a bait-and-switch accusation. It is lifecycle pricing. The honest comparison uses the whole first year, not the number that begins in month seven.

The label matters more than the $3. Oestra is a compounded finished preparation. It is not FDA-approved, and it does not receive FDA premarket review for safety, effectiveness, or quality. Ingredient-level statements do not change the finished product’s regulatory status.

The hidden-cost checklist

Before choosing the smallest number, price all of this:

• Initial consultation
• Required follow-ups and their cadence
• Every prescribed medication, not just estrogen
• Labs and state-specific lab exceptions
• Shipping
• Dose changes
• Billing frequency and amount due at checkout
• Cancellation deadline and nonrefundable portions
• Deductible, copay, coinsurance, and pharmacy benefit

If the recurring provider bill is the actual problem, the fix may be no provider subscription. Midi charges per visit, works with many commercial PPO plans, and sends prescriptions to your pharmacy. Check your coverage and current Midi visit pricing (sponsored link — we may earn a commission).

---

Which alternatives use FDA-approved products, and which use compounded medications?

FDA approval belongs to a specific finished drug product—not to a telehealth company, an ingredient, a pharmacy, or a treatment philosophy. Henry sells both and labels the difference. Alloy’s published menopause hormone products are FDA-approved. Elektra says it prescribes FDA-approved medications only. Winona mixes FDA-approved commercial products with compounded creams. Oestra is compounded.

This is the most abused phrase in online menopause marketing, so the definitions need to stay clean.

Label	What it actually means	What it does not mean
FDA-approved drug product	FDA reviewed a specific finished product for quality, safety, and effectiveness for one or more labeled uses	That every use is on-label, or that every product containing the ingredient is approved
FDA-approved product used off-label	A clinician prescribes an approved product for a use not stated in its approved labeling	That the product itself is unapproved
Compounded preparation	A pharmacy prepares a patient-specific or office-use product under applicable compounding law	FDA did not approve the finished product or conduct premarket review of it
503A pharmacy	Generally compounds prescriptions for identified individual patients under section 503A and state pharmacy oversight	“FDA-approved pharmacy” or FDA approval of its finished compounded products
503B outsourcing facility	Registers with FDA and is subject to federal requirements and inspection associated with outsourcing-facility status	FDA approval of each compounded finished drug
Bioidentical	Describes a hormone with the same chemical structure as an endogenous hormone	“Compounded,” “safer,” “more natural,” or “FDA-approved” by itself

Do not use an NDC as an FDA-approval shortcut

An NDC does not settle the question.

FDA states that assignment of a National Drug Code does not denote FDA approval, and the NDC Directory can contain compounded products reported by outsourcing facilities. An NDC can help identify the labeler, product, and package. It is not an approval badge.

Use this verification sequence instead:

1. Ask for the exact drug name, strength, dosage form, manufacturer or labeler, and package information.
2. Search the exact finished product in Drugs@FDA or the Orange Book.
3. Read the dispensed label. If the provider says the medication is compounded, treat the finished medication as not FDA-approved even if the ingredient also appears in approved drugs.

Where provider-owned pages create avoidable confusion

Winona: Its product-specific FAQ says estrogen patches, estrogen tablets, and progesterone capsules are FDA-approved and its creams are compounded. That is the useful product-level answer. Broader company language has at times described “Winona’s treatments” as compounded, which is too blunt for a mixed catalog. Verify the exact product you will receive.

Inner Balance/Oestra: Inner Balance consistently describes Oestra as compounded, but its pages conflict on whether the dispensing operation is a 503A pharmacy or a 503B outsourcing facility. One page displays a 503A statement; another says 503B. Confirm the actual dispensing pharmacy before paying. Either classification leaves the finished Oestra preparation not FDA-approved.

Inner Balance also uses ingredient-level language suggesting safety because estradiol and progesterone appear in FDA-approved products. That does not transfer approval, clinical-trial evidence, or labeling to the finished compounded Oestra product. We do not repeat its stronger efficacy, absorption, or “testosterone via conversion” claims as established facts.

Henry: Henry’s product-level labels are unusually clear. Its creams are compounded; its patch and tablets are labeled FDA-approved. That is a point in Henry’s favor, not a reason to leave.

Primary regulatory sources: FDA on compounded drugs · FDA NDC Directory · FDA Drugs@FDA

---

Can you really cancel Henry Meds at any time?

You can stop future Henry billing, and Henry says online cancellation is available around the clock in two clicks, with email and phone alternatives. The money-back question is narrower. The terms require cancellation at least 48 hours before renewal, while the refund policy limits most subscription refunds and imposes additional documentation, approval, and fee rules.

There are three different doors.

Door 1: the product-page promise

Henry’s FAQ says you can cancel at any time and says a multi-month balance may remain due unless treatment cannot continue for a medical reason determined by a healthcare provider.

Door 2: the terms of service

The terms say renewals occur automatically unless you cancel at least 48 hours before the end of the current subscription term. They also say online cancellation is designed to be no harder than enrollment and can be completed through the account, email, or phone.

Door 3: the refund policy

For a medical-discontinuation refund on a multi-month subscription, Henry’s policy requires:

• Documentation from an outside MD, DO, NP, or PA stating that continued therapy is medically contraindicated
• Review and approval by Henry’s clinical team
• Proration to the unused part of the subscription
• No refund for medication already dispensed
• Deduction of the nonrefundable $30 consultation component after a prescription is issued
• Possible deduction of an additional processing fee whose amount is not published

“Cancel future renewals” and “receive money back” are not the same promise.

What Henry gets right

We are not printing only the hard clauses.

• Henry publishes a 24/7 online cancellation path.
• If the free evaluation finds you ineligible before enrollment, the terms say you are not enrolled and not charged.
• The product page distinguishes compounded products from FDA-approved products.
• The program schedule publishes dose ceilings that many competitors never publish at all.
• The refund policy explains the outside-documentation requirement instead of leaving “medical reasons” undefined.

The arbitration opt-out most people will never see

Henry’s terms require binding individual arbitration and waive class proceedings unless you opt out in writing within 30 days after first accepting the terms. The notice must include your name, account email, mailing address, phone number, and a clear opt-out statement. Henry permits notice by email to legal@henrymeds.com or by mail to the legal address in its terms.

If you are inside that 30-day period and care about preserving court rights, read the arbitration section itself. This is a plain-language summary of contract terms, not legal advice.

The safest operational rule: cancel at least 48 hours before renewal, keep the timestamped confirmation, and ask for the exact refund calculation in writing before assuming any prepaid amount will come back.

---

Is Midi Health a better Henry Meds alternative?

Midi is the strongest alternative for many women leaving Henry because they want commercial PPO insurance and do not want a provider membership fee. It is available nationwide, publishes $250 initial and $150 follow-up self-pay visit prices, and sends prescriptions to the patient’s pharmacy. It is a poor fit for Medicare coverage and cannot treat Medicaid or Medi-Cal patients at all.

Midi is our first recommendation for the prescription-not-subscription reader—and before the value case, here is what is wrong with it.

What we would change about Midi

Midi does not give cash-pay patients one all-in number. Henry’s $149 package can cover the clinical encounter, prescribed medication within the program schedule, supplies, and shipping. Midi’s $250 self-pay initial price covers the visit. Medication and labs are separate. A first cash visit is $101 more than one month of Henry before the pharmacy bill arrives.

If one predictable monthly payment is the thing keeping your life manageable, Henry is simpler. If you have Medicaid or Medi-Cal, Midi is not an option even if you offer to pay cash. If you have Medicare, Midi says you may self-pay but cannot submit claims related to Midi care.

But because Midi bills eligible commercial insurance and sends the prescription to your own pharmacy, the care model solves three problems a bundled shipment cannot:

• The provider does not charge a mandatory membership fee.
• Your medication can run through your pharmacy benefit.
• You can compare pharmacies, prior-authorization rules, and exact product coverage instead of accepting one fulfillment channel.

That is the failure mode many readers are trying to escape.

What Midi costs

• Self-pay first visit: $250
• Self-pay follow-up: $150
• Commercial insurance: plan-specific copay, coinsurance, or deductible; confirm with the carrier
• Medication: separate
• Labs: separate when ordered
• Membership fee: none published for menopause care

What about testosterone through Midi?

Midi publishes a women’s testosterone pathway in a limited group of states. It labels the medication compounded, starts with clinician evaluation and laboratory monitoring, and notes that there is no FDA-approved testosterone product specifically indicated for women in the United States.

Testosterone is a Schedule III controlled substance. It requires a prescription, clinical judgment, state-law eligibility, monitoring, and follow-up. Do not treat online availability as guaranteed access.

What a patient says about the service model

“Midi was so easy: I got a same day appointment and they took my insurance.” — Victoria W.

Company-published testimonial. Individual experience, not independently verified, not necessarily typical, and not evidence of treatment safety or effectiveness.

Does this sound like your situation—you want an insured clinical relationship and your own pharmacy, not another all-in shipment? Check Midi coverage and current visit pricing (sponsored link — we may earn a commission).

Primary sources: Midi menopause care and pricing · Midi HRT coverage rules

---

Is Alloy a better Henry Meds alternative?

Alloy is the clearest cash-pay alternative when you need one FDA-approved menopause medication and want the product price separated from the consultation. It charges a $49 one-time consultation, then lists each product independently: estradiol tablets from $39.99 a month, gel or Evamist at $69.99, a patch at $100, and progesterone from $23.

Alloy belongs near the top because removing it would make the comparison worse.

Where Alloy wins

If a clinician prescribes estradiol tablets alone, the published first-year arithmetic is $528.88 including the consultation. The patch is $1,249. Those numbers are far below Henry’s $1,788 bundle because Alloy is pricing one product, not a broad package.

Alloy’s public menopause-hormone catalog is also unusually easy to audit. It names the route, one-month equivalent price, supply interval, and FDA-approved status on product pages.

Where Henry wins

The clean per-product model gets less clean when your regimen needs multiple products.

A patch at $100 per month plus progesterone from $23 per month produces a minimum first-year illustration of $1,525 after the consultation. Add another product and the gap can disappear. Henry may also offer a direct provider encounter, while Alloy’s standard model centers on intake and messaging.

Compare the whole prescribed regimen, not one Alloy product against the whole Henry package.

Who Alloy is for

Alloy is a strong fit when:

• You are paying cash
• You want an FDA-approved menopause medication
• You only need one or two clearly priced products
• You are comfortable with an asynchronous care model
• You do not need testosterone through the platform

It is not the obvious fit when insurance could pay, you want live video, or your regimen stacks several products.

Primary sources: Alloy hormone-therapy catalog · Alloy estradiol patch

---

Is Sesame a better Henry Meds alternative?

Sesame’s menopause program currently starts at $59 a month for care, with medication billed separately through the patient’s pharmacy. It includes video care, messaging, and basic lab work when clinically necessary. That makes it a lower published care-subscription price than Henry—but not a $59 all-in HRT program.

Sesame’s current menopause service page publishes from $59/month and explicitly says medication is not included.

That correction matters because Sesame can now be compared honestly:

• Care subscription: from $59/month
• Annual care-fee arithmetic: $708
• Medication: separate and dependent on insurance status and pharmacy
• Visit format: video plus messaging
• Labs: basic lab work included if the clinician finds it necessary
• Insurance: Sesame does not bill the subscription to insurance
• Controlled substances: its standard online model does not provide testosterone prescribing

Where Sesame wins

Sesame publishes an actual formulary rather than vague “personalized HRT” language. The current menopause page names estradiol products, estrogen/progestin combinations, progesterone, prasterone, and nonhormonal options. That gives you a better chance of checking the exact product path before paying.

The basic-lab promise is also more concrete than Henry’s women’s program schedule. Henry’s terms say affiliated-lab costs are included when labs are ordered, but its women’s program entry does not promise a routine panel. Sesame says basic lab work is included if necessary.

Where Sesame loses

Medication is not in the $59 price. A reader who wants one predictable all-in number may end up preferring Henry even though Henry’s headline is higher. And anyone seeking testosterone needs another route because controlled-substance prescribing is not part of Sesame’s standard online menopause service.

If included basic lab work and a low care fee solve the exact gap you found at Henry, confirm the pharmacy cost before you book. See Sesame’s current menopause price and availability (sponsored link — we may earn a commission).

Primary source: Sesame menopause treatment

---

Is Winona a better Henry Meds alternative?

Winona is the closest structural alternative to Henry: cash-pay telehealth, shipped medication, product subscriptions, and no insurance billing. But it does not solve Henry’s age gate—Winona also limits HRT treatment to ages 35 through 59. Its product-level regulatory status is mixed: commercial patch, tablets, and capsules are labeled FDA-approved; creams are compounded.

Read the age sentence twice.

If you are leaving Henry because you are turning 60, Winona cannot fix the problem. Same wall, different logo. Go to Stella, Alloy, Elektra, MyMenopauseRx, Gennev, or your own clinician instead.

Current public prices

Winona’s product catalog currently lists:

• Estrogen patch from $149/month
• Progesterone capsules from $39/month
• Estrogen tablets from $54/month
• Estrogen body cream from $89/month
• Estrogen body cream with progesterone from $89/month
• Vaginal estrogen cream from $89/month

Winona’s current product pages present monthly prices. We could not confirm that an older every-28-day cadence still governs every product, so the comparison uses the published monthly components and tells you to verify the checkout cadence rather than inventing an annual charge count.

A patch-plus-progesterone illustration is $188 per advertised month, or $2,256 over twelve advertised monthly periods. That is an illustration, not a guaranteed treatment plan or checkout total.

The damaging admission

Winona does not offer the same live-visit experience Henry presents. Its care model is built around online intake and doctor messaging. If face-to-face video matters, that is a downgrade.

But if you want medication shipped, do not want insurance involved, and prefer messaging over appointments, the same feature becomes the point. Winona removes scheduling friction.

The FDA-status answer

Winona’s current FAQ gives the clearest product-level split:

• Estrogen patch: FDA-approved
• Estrogen tablets: FDA-approved
• Progesterone capsules: FDA-approved
• Compounded creams: not FDA-approved

Do not accept the sentence “Winona is FDA-approved” or “Winona is compounded.” Neither is precise enough. Get the exact product.

Winona fits only if you are 35–59, want shipped medication, accept messaging-based care, and have confirmed the exact product and billing cadence. Check Winona’s current treatment options (sponsored link — we may earn a commission).

Primary sources: Winona product catalog · Winona eligibility and medication FAQ

---

Is Inner Balance’s Oestra a better Henry Meds alternative?

Oestra is one compounded vaginal preparation containing estradiol and micronized progesterone, marketed for whole-body effects. It costs $199 a month for six months and $99.50 afterward, producing a $1,791 first-year total—$3 more than Henry’s $1,788 base. It is not FDA-approved, and dose adjustments may add cost.

The strongest thing about Oestra is also its biggest constraint: it is one product.

One daily application can be simpler than managing a separate patch and capsule. But there is no patch choice, oral choice, or clearly separated low-dose local-vaginal option inside the same program. If the route or combined formulation does not fit, the platform’s flagship answer does not fit.

The public-page conflicts you need to see

Inner Balance’s own pages describe the dispensing operation as 503A in one place and 503B in another. That is not a cosmetic distinction. Ask for the dispensing pharmacy’s legal name and current status before providing payment or health information.

The company also uses language such as “testosterone via conversion” even though Oestra’s stated active hormones are estradiol and progesterone. That is not the same as receiving a prescribed testosterone product, and it should never be compared with a testosterone prescription.

And the finished-product line stays bright: Oestra is compounded. The fact that estradiol and micronized progesterone also appear in FDA-approved products does not make this combined compounded cream FDA-approved or clinically interchangeable with those products.

Who should consider it

Oestra belongs on the page because some women value one combined application and ongoing cash pricing. It should be considered only after a prescribing clinician has evaluated whether the route, dose, endometrial protection strategy, and monitoring plan fit the individual patient.

It is not the obvious cost-saving switch during the first year. The arithmetic closes that door.

Primary sources: Oestra product page · Inner Balance FAQ

---

What about Elektra Health, Stella, MyMenopauseRx, and Gennev?

These four clinics solve the part Henry cannot: they operate as visit-based menopause care rather than an all-in medication subscription. Elektra has the clearest published Medicare and Medicaid pathway in selected states, Stella extends its stated age range to 70, MyMenopauseRx publishes $150 self-pay visits, and Gennev offers nationwide video appointments at $250 initial and $199 follow-up.

Elektra Health: the Medicare and Medicaid door—where it is actually open

Elektra states that it accepts selected commercial insurance, Medicare, and Medicaid plans. Its current FAQ publishes the plan and state combinations instead of pretending the word “Medicare” means nationwide access.

Examples on Elektra’s current list include Medicare in New York, Connecticut, Massachusetts, Florida, and Pennsylvania; Medicaid appears for selected plans in New York and Pennsylvania. That list can change, and plan names matter. Do not book from the headline alone.

Elektra says it prescribes FDA-approved hormonal and nonhormonal medications rather than compounded HRT. It also publishes a limited testosterone pathway for New York patients, subject to clinician judgment and controlled-substance rules.

Best for: a woman with a listed Medicare, Medicaid, or commercial plan who wants a live menopause-focused visit and FDA-approved medication options.

Not for you if: your state or exact plan is not on Elektra’s current coverage list and the self-pay price does not work.

Primary sources: Elektra insurance FAQ · Elektra insurance explainer

Stella: the cleanest age-gate alternative

Stella states that its U.S. virtual menopause clinic is designed for women 35 to 70. Its published self-pay prices are $200 for an initial visit and $90 for follow-ups. It also advertises in-network care, with the actual amount depending on the plan.

That makes Stella one of the most direct answers for a woman Henry excludes at 60. It does not mean every 60-to-70-year-old should start or continue systemic hormone therapy. It means Stella will evaluate women in that age range instead of rejecting them at the intake gate.

Best for: the woman whose problem is Henry’s age policy and who wants a live menopause clinic.

Not for you if: your exact insurance is not accepted and you want an all-in medication bundle.

Primary source: Stella U.S. FAQ

MyMenopauseRx: insurance-oriented care with a current $150 self-pay visit

MyMenopauseRx’s current treatment-cost page says $150 per virtual visit for self-pay patients. Older $99 references are stale and should not be used for a current comparison.

The company lists major insurers, sends prescriptions to the pharmacy of your choice, and offers discounted self-pay lab pricing. It markets FDA-approved therapeutic options and menopause-specialist care.

Best for: a woman who wants a menopause-focused clinician, a pharmacy prescription, and a chance to use insurance.

Not for you if: you want medication, shipping, and visits bundled into one payment.

Primary source: MyMenopauseRx treatment costs

Gennev: nationwide video care, but higher self-pay visit fees

Gennev publishes video availability in every state. Its self-pay doctor prices are $250 for the initial visit and $199 for follow-ups, with medication separate. It also accepts insurance, but network status depends on the specific plan shown in its coverage tool.

The damaging admission is obvious: two cash visits total $449 before medication and labs. Henry can cost less for a cash payer who values the bundle.

The pivot is equally obvious: Gennev is a menopause-focused clinical relationship with 30-minute appointments and prescriptions sent to your pharmacy. You are buying clinician time and flexibility, not a medication shipment.

Best for: women who want nationwide live menopause care and their own pharmacy.

Not for you if: the $250/$199 visit structure costs more than the simplicity you are trying to replace.

Primary source: Gennev insurance and pricing

---

Which online menopause providers actually bill insurance?

Insurance-friendly menopause care is still a short list. Midi works with many commercial PPO plans nationwide but excludes Medicaid/Medi-Cal and does not cover Medicare. Elektra publishes selected commercial, Medicare, and Medicaid plans by state. Stella, MyMenopauseRx, and Gennev also advertise insurance pathways. Henry, Alloy, Sesame, Winona, and Oestra are primarily cash-pay routes.

Provider	What it publicly says about insurance	What you must verify
Midi Health	In-network with most PPO plans; nationwide care	Exact plan, clinician network status, deductible, lab benefit, and pharmacy benefit; no Medicare coverage and no Medicaid/Medi-Cal treatment
Elektra Health	Selected commercial, Medicare, and Medicaid plans	Exact state, product, referral requirement, and network status
Stella	Advertises in-network menopause care and self-pay options	Exact plan and state; whether a superbill or direct in-network billing applies
MyMenopauseRx	Lists major insurance plans and $150 self-pay visits	Exact state and plan network status
Gennev	Insurance accepted with a plan-specific coverage list	Whether your plan is in-network, out-of-network, or self-pay

Insurance touches three different bills:

1. The clinical visit
2. The laboratory work
3. The prescription

A logo strip is not a coverage determination. Ask your carrier about all three, document the reference number, and confirm that the clinician—not merely the company—is in-network for the scheduled date.

For Medicare and Medicaid, “we accept government insurance” is still not enough. A provider can participate in one state, one managed-care plan, or one product while being unavailable everywhere else. Elektra is the strongest published online lead, not a universal guarantee.

---

When is Henry Meds still the right choice?

Henry remains a rational choice for an eligible cash-pay woman who wants one $149 number, home delivery, and a choice between clearly labeled compounded creams and FDA-approved patch or tablet options. Switching is not automatically an upgrade. If Henry answers the four fine-print questions and the bundle reduces more friction than it creates, staying may be the better decision.

Stay if

• You are 35 to 59 and eligible where you are physically located for the visit.
• Cash-pay care is acceptable.
• One predictable payment matters more than optimizing every line item.
• You want medication shipped.
• The published dose ceilings cover the plan your clinician recommends.
• Henry confirms your lab plan, refill interval, exact product, and total price in writing.
• You want a direct provider encounter rather than messaging alone.

Leave if

• Insurance would materially lower your total cost.
• Henry’s age policy excludes you.
• You have Medicare or Medicaid and an in-network route is available.
• You only need one medication and the bundle is charging you for convenience you do not use.
• You want to choose the pharmacy.
• You need a route, dose, or monitoring plan Henry does not publish or confirm.
• You need in-person examination, imaging, or coordinated specialty care.

Two common exit reasons may not require leaving at all.

If your concern is compounded medication: Henry’s patch and tablets are labeled FDA-approved. Ask whether one is clinically appropriate for you.

If your concern is not knowing what the $149 covers: ask the four questions before rebuilding the entire care setup.

And one possibility deserves to be named: you may need a different clinician inside the same service, not a different company. A poor clinical fit and a bad care model are not always the same problem.

The right reason to switch is that a different care model fits your life better—not that another homepage shows a smaller number.

---

Why does Henry Meds have an F rating with the BBB?

The Better Business Bureau currently lists Henry Meds as not accredited with an F rating. As of August 17, 2026, the profile shows 232 complaints filed in the preceding three years and 26 unanswered. BBB identifies both the complaint total and the unanswered complaints as reasons for the rating. This is a customer-service signal, not a clinical-safety finding.

The count moves as new complaints and responses are posted. That is why the figure needs a verification date.

BBB’s current complaint categories include product issues, service or repair issues, billing issues, sales and advertising issues, customer-service issues, delivery issues, and order issues. The profile does not establish that every allegation is true, and the total is not a complaint rate because BBB does not publish Henry’s customer count.

The number that matters most to the grade is not one horror story. It is the pattern of 26 complaints with no business response.

The counterweight

Henry’s current Trustpilot page shows an “Excellent” score around 4.5 out of 5 across roughly 13,000 reviews and says the company replies to 98% of negative reviews. That is a large pool of favorable service experiences and should not be erased because BBB is negative.

One recent Trustpilot reviewer wrote:

“Quick and easy visit, and my medication was refilled right away. Cost is still quite high though.” — Mabel Cavanagh

Public service review. Individual experience, not independently verified, not necessarily typical, and not evidence of medical effectiveness or safety.

BBB and Trustpilot measure different pools with different collection and scoring systems. Do not average them. Do not turn either into a medical-quality score. Read them as operational evidence about billing, communication, fulfillment, and response behavior.

For comparison, Midi is BBB-accredited with a B rating and currently has 164 complaints in the BBB window. That does not prove Midi provides better clinical care. It does show a different current BBB posture. Affiliate status does not change either record.

Sources: Henry Meds BBB profile · Henry Meds Trustpilot profile · Midi BBB profile

---

Why is Hers not one of the ten primary recommendations right now?

Hers offers menopause care, but we are not making it a primary recommendation on a page centered on subscription billing, cancellation, and health-data trust while a current federal case addresses those exact issues. On July 29, 2026, the FTC, California, and Utah filed a pending action alleging deceptive billing, cancellation, and sensitive-health-data practices by Hims & Hers.

Those are allegations in a pending case, not findings of liability. Hims & Hers has the right to contest them.

The proportionate editorial decision is not “Hers is unsafe” or “never use Hers.” It is this: we will not place an affiliate CTA to Hers inside a billing-fine-print page while the case is pending and current menopause pricing and plan terms have not been reverified to the same standard as the ten routes above.

One separate accuracy point survives: when Hers says hormone therapy is not FDA-approved for perimenopause, that can describe the approved indication rather than the regulatory status of every dispensed product. FDA-approved medications can be prescribed off-label. Never paraphrase that sentence into “Hers medications are not FDA-approved” without checking the exact product.

Primary source: FTC Hims & Hers case page

---

Did you mean alternatives to hormone therapy itself?

That is a different question. This page compares alternatives to Henry Meds as a provider. FDA-approved nonhormonal prescriptions, off-label medicines, and non-drug options exist for specific menopause symptoms, but they do not all treat the same problems and should not be collapsed into one “natural HRT alternative” list.

For the medication-by-medication answer, use our guide to alternatives to HRT.

The important distinction here is symptom target. A treatment for hot flashes is not automatically a treatment for vaginal dryness, painful sex, sleep disruption, or bone-loss prevention. A provider comparison cannot substitute for choosing the right clinical target.

---

When is online HRT not the right starting point?

Online menopause care works for many women, but it cannot replace every examination, image, biopsy, or specialist conversation. Prompt in-person or coordinated evaluation is the better starting point for unexplained bleeding after menopause, severe or unexplained pelvic symptoms, an urgent new symptom, or a history that requires cancer, clotting, liver, cardiovascular, or other specialist input.

Bleeding after menopause needs evaluation

Any vaginal bleeding after menopause warrants prompt clinical evaluation. It is not a “finish the intake form and see what happens” symptom. ACOG guidance supports prompt assessment and describes transvaginal ultrasound or endometrial sampling as initial approaches depending on the situation.

That does not mean every episode is cancer. It means the cause needs to be established before a telehealth subscription becomes the center of the plan.

Progesterone is not a casual add-on to systemic estrogen

For a patient with a uterus using systemic estrogen, adequate endometrial protection with a progestogen is generally needed unless the clinician selects another appropriate protective strategy. That is different from low-dose local vaginal estrogen, where routine progestogen is generally not required under major menopause guidance.

Do not let a comparison table decide this. Ask the prescriber to state whether the estrogen is systemic or local, what protects the endometrium, and how bleeding should be handled.

Age alone is not the safety screen

Henry and Winona stop their online HRT programs before age 60. That is their eligibility policy. The Menopause Society does not treat 60 or 65 as an automatic stop date for every woman already using hormone therapy. Continuing, changing, or starting treatment requires individualized assessment of benefits, risks, route, dose, and goals.

Testosterone requires a real controlled-substance pathway

Testosterone is Schedule III in the United States. There is no FDA-approved testosterone product specifically indicated for women. A legitimate online pathway still requires a prescription, clinician judgment, state eligibility, baseline and follow-up monitoring, and compliance with controlled-substance rules.

A button that says “testosterone available” is not permission, a diagnosis, or a guaranteed prescription.

Medical sources: ACOG on postmenopausal bleeding · The Menopause Society on hormone therapy · DEA drug scheduling

---

What should you verify before paying any online HRT provider?

Confirm the exact finished medication, regulatory status, dispensing pharmacy, full amount due, renewal cadence, lab plan, state eligibility, insurance handling, cancellation deadline, refund deductions, follow-up access, and health-data practices. A provider that cannot answer those questions clearly should not receive your payment or your medical history.

The first six questions work for every provider. The last six exist because we read Henry’s documents against each other.

1. What is the exact drug name, strength, route, and dosing schedule the clinician is considering?
2. Is the exact finished product FDA-approved or compounded? Where can I verify it in Drugs@FDA or the Orange Book?
3. Which pharmacy will dispense it, and is that the final pharmacy rather than one possible partner?
4. Is the quoted price for clinical care, medication, labs, shipping, or all of them?
5. What is charged today, at prescription, at shipment, and at renewal?
6. If I am found ineligible or decline the treatment plan, what amount is nonrefundable?
7. Are clinician-ordered labs included through the provider’s network, and which labs are actually expected for my plan?
8. What is the refill interval for my exact patch, tablet, or cream?
9. Is Henry’s vaginal cream included in the standard $149 women’s HRT price?
10. What happens if my prescribed route or dose is outside Henry’s published program limits?
11. What processing fee can be deducted from an approved refund?
12. Am I still within Henry’s 30-day arbitration opt-out period?

Two rules about order matter just as much as the questions.

Ask whether the new clinician can evaluate continuation of your current regimen. Do not demand a guaranteed prescription. A legitimate clinician cannot promise one before evaluating you.

Do not stop, restart, overlap, or change prescription hormone therapy from an article. Ask the new and current prescribers for a written transition plan, secure the new supply when appropriate, and then time cancellation around the renewal deadline. The exact sequence is clinical, not merely administrative.

Run your age, state, insurance, route preference, and key safety flags before you start another intake. Open Find My HRT Path.

---

How do you switch without losing the information you need?

Preserve the record first, verify the new provider’s eligibility rules second, and cancel last. Screenshot the current prescription, dose, billing history, renewal date, and cancellation terms before portal access changes. Then complete the new clinical evaluation and follow the prescribers’ transition instructions rather than creating your own medication overlap.

Use this order:

1. Save the current record. Capture the medication name, manufacturer if shown, strength, route, dose, pharmacy, last shipment, billing history, renewal date, and cancellation policy.
2. Check the new provider’s gate. Confirm age, physical location for the visit, state licensure, insurance, preferred medication route, and whether controlled substances are relevant.
3. Confirm the money before intake. Ask what is due for the visit, labs, medication, shipping, and first renewal.
4. Complete the new clinical evaluation. Bring your current label and ask whether the clinician can evaluate continuation or recommends a different plan.
5. Get written transition instructions. Do not guess about stopping, overlapping, or changing doses.
6. Cancel the old subscription at the right time. For Henry, use the 48-hour renewal rule and keep the confirmation.
7. Check the next statement. A cancellation email is useful; a statement without the renewal charge is the final operational confirmation.

If you are already on a prepaid multi-month Henry plan, pause the provider shopping for one moment. Ask Henry in writing for the remaining balance, whether a refund exception could apply, exactly what outside documentation is required, and every deduction that would be made. Know the exit cost before you create a second bill.

---

How did The HRT Index verify this comparison?

We read provider-owned price pages, treatment catalogs, insurance FAQs, terms, refund policies, and regulatory disclosures on August 17, 2026. For Henry, we compared four separate documents line by line. Medical and regulatory claims were checked against FDA, DEA, ACOG, and The Menopause Society sources. We did not assign provider scores or infer unpublished prices.

What we actually verified

Source	Date stated by source	What it established
Henry women’s HRT page	No page-update date shown	$149 price, age gate, included categories, product-level FDA-approved/compounded labels, FAQ language
Henry program schedule	December 3, 2025	Dose ceilings, women’s options, $100 testosterone add-on, difference between men’s lab language and women’s entry
Henry terms	August 6, 2026	Self-pay terms, lab workflow and costs, $30 consultation component, cancellation mechanics, arbitration opt-out
Henry refund policy	No update date shown	Medical-discontinuation test, prorating, final-sale rule, processing-fee language
Provider treatment and pricing pages	Checked August 17, 2026	Current public prices, billing models, product status, insurance statements, and care format
FDA, DEA, ACOG, and The Menopause Society	Current pages checked August 17, 2026	Compounding status, NDC limitation, controlled-substance schedule, bleeding guidance, and age/progestogen context

This page follows The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule—top providers monthly, the full roster quarterly.

We evaluate the decision using five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not collapse them into a numeric provider score because the same provider can be the right answer for an insured 47-year-old and the wrong answer for a 61-year-old Medicare beneficiary.

What remains intake-dependent

We did not invent answers to these:

• Henry’s complete women’s HRT state list
• The amount of Henry’s possible refund processing fee
• Whether Henry’s compounded vaginal cream is included at $149
• The refill interval for every Henry patch or cream
• The exact drug any clinician will prescribe
• An individual insurance determination
• Elektra’s eligibility for a plan not shown on its current list
• Inner Balance’s actual dispensing pharmacy classification where its pages conflict
• A guaranteed Winona billing cadence or regimen beyond current advertised product prices

Those are not omissions to hide. They are the questions to take into intake.

Refresh schedule

• Monthly: Henry’s four documents, all provider prices, subscription terms, BBB profiles, and affiliate links
• Quarterly: state availability, age gates, insurance lists, formularies, FDA/FTC actions, pharmacy disclosures, and testosterone pathways
• At every update: redo all arithmetic from the current public components; never carry a total forward because the headline looks unchanged

---

Frequently asked questions

How much does Henry Meds HRT cost per month?

Henry Meds publishes a $149 monthly women’s HRT price. Its program schedule lists estrogen and progesterone options within dose ceilings. Compounded testosterone cream is an additional $100 per month if prescribed, producing a $249 monthly total for that combination.

What is the age limit for Henry Meds women’s HRT?

Henry says patients must be at least 35 and below 60 to be considered for its women’s HRT program. That is a provider eligibility rule, not a universal medical rule that hormone therapy must stop at 60.

What is the best Henry Meds HRT alternative?

For many commercially insured women, Midi Health is the strongest alternative because it has no provider membership fee and sends prescriptions to the patient’s pharmacy. Elektra is the better lead for eligible Medicare or Medicaid plans, Alloy for one clearly priced FDA-approved medication, and Stella when Henry’s age gate is the problem.

Is Henry Meds women’s HRT FDA-approved?

Some products are; some are not. Henry labels its estradiol patch and tablets FDA-approved, while its body cream and vaginal cream are compounded. The testosterone cream add-on is also compounded. Regulatory status must be checked product by product.

Does Henry Meds take insurance?

No. Henry’s women’s HRT program is self-pay. Its terms say it does not participate in Medicare, Medicaid, or commercial insurance and does not submit claims. Verify HSA/FSA eligibility with the account administrator rather than assuming reimbursement.

Does Henry Meds include laboratory work?

Henry’s terms say the cost of laboratory services ordered through its affiliated Quest or Tasso workflow is included in the subscription or total platform charges. The women’s HRT program schedule does not promise a routine lab panel or cadence. Ask what your clinician expects and whether every ordered test is inside the plan.

Can I cancel Henry Meds at any time?

You can request cancellation of future service, and Henry publishes an online cancellation path. To protect against renewal, use the terms’ stricter 48-hour-before-renewal deadline. Refunds are narrower and may be reduced by a $30 consultation component and an unpublished processing fee.

Does Henry Meds offer vaginal estrogen?

Henry’s product page shows a compounded vaginal cream. The women’s program schedule does not list it among the $149 options. Confirm the exact formula, intended local or systemic use, price, refill interval, and compounded status before the prescription is issued.

Does Henry Meds prescribe testosterone for women?

Henry publishes a compounded testosterone cream add-on for an additional $100 per month if prescribed. Testosterone is Schedule III, requires a prescription and clinical monitoring, and has no FDA-approved product specifically indicated for women in the United States.

Is an NDC proof that a medication is FDA-approved?

No. FDA explicitly says an NDC does not denote approval, and compounded products can appear in the NDC Directory. Verify the exact finished product through Drugs@FDA or the Orange Book and read the dispensed label.

Is Henry Meds cheaper than Winona?

Henry’s published base is $1,788 over twelve months. Winona currently lists individual products rather than one universal bundle: a patch from $149 per advertised month and progesterone capsules from $39. A patch-plus-progesterone illustration is $188 per advertised month, but the actual regimen and billing cadence must be confirmed at checkout.

Is Henry Meds cheaper than Oestra?

In the first year, yes—by $3 on the published base prices. Henry is $1,788. Oestra is $199 per month for six months and $99.50 for six months, totaling $1,791. Oestra becomes cheaper at its ongoing rate after month six, but it is compounded and not FDA-approved.

What is the cheapest Henry Meds alternative?

There is no universal cheapest route because visit, lab, and medication costs are split differently. For one cash-pay medication, Alloy’s published estradiol-tablet illustration is $528.88 in year one including the consultation. A local clinician plus an insured or discounted generic prescription may cost less, but you need a live quote.

Do I need progesterone if I take estrogen?

If you have a uterus and use systemic estrogen, adequate endometrial protection with a progestogen is generally needed unless your clinician selects another appropriate strategy. Low-dose local vaginal estrogen is different and generally does not require routine progestogen. Your prescriber should identify which category your product falls into.

Is compounded HRT the same as bioidentical HRT?

No. “Bioidentical” describes chemical structure. “Compounded” describes how the finished preparation is made. FDA-approved estradiol patches and micronized progesterone capsules can be bioidentical; compounded preparations can also contain bioidentical hormones. The words are not synonyms.

Why does Henry Meds have an F rating with the BBB?

BBB currently cites 232 complaints in three years and 26 unanswered as reasons for Henry’s F rating. That is an operational customer-service signal, not an FDA action or clinical-safety finding. The count is dated August 17, 2026 and will change.

Which alternative accepts Medicare or Medicaid?

Elektra publishes selected Medicare and Medicaid plans in specified states. Coverage is not nationwide and must be verified by exact plan. When Elektra is not available, the honest answer may be a local in-network menopause clinician rather than another cash-pay subscription.

Is age 60 too old for hormone therapy?

Not automatically. Henry and Winona use 60 as a program eligibility boundary. The clinical decision depends on symptoms, time since menopause, prior treatment, medical history, route, dose, and goals. The Menopause Society does not support an automatic stop for every woman at 60 or 65.

---

Still not sure which HRT program is right for you?

Do not pick from ten logos. Match the decision to your state, insurance, age, medication route, uterus status, and the reason you are leaving Henry—and flag the situations that need in-person care first.

→ Use Find My HRT Path

---

This article is educational research, not medical advice, and has not been medically reviewed by a clinician. Prices, policies, formularies, insurance contracts, and availability change. Every commercial claim above was verified in August 2026. Found something out of date? Tell us.